Abstract: . . .  Advances in Arrhythmia Surgery John H. Sirak, M.D. John H. Sirak, M.D. Assistant Professor of Cardiac Surgery Assistant Professor of Cardiac Surgery The Ohio State University The Ohio State University Page 2 Epidemiology of AF Incidence of 2.2 million in the U.S Incidence of 2.2 million in the U.S 160,000 new cases annually 160,000 new cases annually Occurs in 6% of patients over age 65 Occurs in 6% of patients over age 65 Prevalence doubles with each advancing decade Prevalence doubles with each advancing decade 70% of patients with atrial fibrillation have overt 70% of patients with atrial fibrillation have overt  . . .
. . .  control drugs Page 10 Futility of Medical Management of AF RACE: Symptomatic patients had better quality RACE: Symptomatic patients had better quality of life when in NSR, regardless of treatment of life when in NSR, regardless of treatment strategy strategy All studies only enrolled patients with option for All studies only enrolled patients with option for rate control rate control Overall 3 Overall 3 - - yr mortality about 25% regardless of yr mortality about 25% regardless of strategy strategy Page 11 Stroke Rates In Atrial Fibrillation : Nonsurgical vs Surgical Therapy Risk factors, prior TE, no Coumadin Risk factors, no prior TE, no Coumadin Risk factors, prior TE, Coumadin Risk factors, no prior TE, Coumadin No risk factors, no prior TE, no Coumadin Maze procedure Ad N, Semin Thorac Cardiovasc Surg 2000;12:56-62. Page 12 Maze III: Right Atrial Lesions Page 13 Maze III: Left Atrial Lesions Page 14 Cox Maze III: Pro/Con Pros Pros High cure rate High cure rate Proven long Proven long - - term . . .
--3000,2,750,2488,17761